The year 2018 was epic for the Japanese pharmaceutical industry, largely because of the fundamental National Health Insurance (NHI) pricing reforms implemented in April, says …

There are just over 12 months to go until the EU Medical Device Regulation (MDR) enforcement deadline of May 2020. This is driving major efforts …

In this article, Jim Robertson at Wynne Jones IP discusses how uncertainty surrounding a potential no-deal Brexit has created a deep chasm in opinion in …

It makes no sense that product data exists separately in ERP and RIM systems, compromising any efforts to improve efficiency through tighter inter-function collaboration. A …

The new In Vitro Diagnostic Medical Devices Regulation (IVDR), EU 2017/746, was published in the Official Journal of the European Union in May 2017 with …

The rise of digital impacts the life sciences industry in multiple ways, says Emma Hyland at VEEVA. When it comes to content, it is fundamentally …

Businesses throughout the pharmaceutical supply chain can now develop collaborative solutions that will fundamentally change the way the industry shares information. The potential to provide …

The first germline transmission-capable transgenic mice were developed in the early 1980s in the laboratories of Frank Ruddle (Yale), Ralph Brinster (University of Pennsylvania), and …

The pharmaceutical landscape continues to evolve, with much R&D focusing on more specialised medicines. As the biological activity and specificity of the API increases, dosage …

There are several methods for achieving cell disruption; however, high-pressure homogenisation (HPH) / microfluidisation is the standard approach for the scale of this client’s microbiological …